Mallinckrodt Creditors Say Ch. 11 Plan Understates Revenues
Senior creditors of bankrupt drugmaker Mallinckrodt Corp. have objected to confirmation of its multibillion-dollar Chapter 11 plan, arguing that the company failed to take into account worldwide revenues from a breakthrough...To view the full article, register now.
Already a subscriber? Click here to view full article